Aju Ib Investment Co., Ltd. Rapt Therapeutics, Inc. Transaction History
Aju Ib Investment Co., Ltd.
- $58.4 Million
- Q3 2022
A detailed history of Aju Ib Investment Co., Ltd. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Aju Ib Investment Co., Ltd. holds 99,503 shares of RAPT stock, worth $124,378. This represents 4.1% of its overall portfolio holdings.
Number of Shares
99,503
Previous 99,503
-0.0%
Holding current value
$124,378
Previous $1.82 Million
31.83%
% of portfolio
4.1%
Previous 3.52%
Shares
2 transactions
Others Institutions Holding RAPT
# of Institutions
100Shares Held
124MCall Options Held
246KPut Options Held
69.6K-
Medicxi Ventures Management (Jersey) LTD22.4MShares$27.9 Million7.76% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA13.1MShares$16.4 Million3.39% of portfolio
-
Orbimed Advisors LLC San Diego, CA13.1MShares$16.4 Million0.56% of portfolio
-
Foresite Capital Management Vi LLC Larkspur, CA12.5MShares$15.6 Million8.8% of portfolio
-
Rtw Investments, LP New York, NY11.8MShares$14.7 Million0.3% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $37.1M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...